What is this webcast about?


The pharmaceutical industry in Europe is heavily regulated across the whole life-cycle of a medicinal product covering the research and development, clinical trials, marketing authorization, HTA processes as well as post marketing and pharmacovigilance. The organization faces a multitude of stakeholders with respective interests and any regulatory change can have a major impact on sales as well as pipeline projects. Prominent examples are the introduction of digital safety features on the packaging of pharmaceutical as well as changes to the sales channels. There is clear need to engage strategically with these health policy stakeholders both at national and European level in order to mitigate risks and set the policy agenda.



Target Group


Market Access, Leadership Team, Communications, Government & Public Affairs functions



What you will learn


This webcast provides an introduction into professional government affairs at European level by explaining the EU legal processes from a government affairs perspective and show potential entry points for effective interest representation. In addition, it will outline the basics of strategy development for government affairs purposes.



Duration and Agenda


In this 50 minutes webcast, Kevin Rieger is going to speak about:
  • Why PA is important for Pharma
  • How does PA work in practice
  • How to develop a PA strategy


Fee


The fee for this webcast is 39,- EURO (plus GERMAN VAT)


Presenter


Kevin Rieger, Public Affairs Manager

Kevin Rieger is a government affairs specialist with many years of experience working in the pharmaceutical industry and the European institutions. He has led the Brussels Office of the German Trade Association (BPI) and has obtained a Masters in European Public Health from Maastricht University.